by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Hospitals have a newfound cushion of time to meet stage 3 meaningful use measures, which they now won’t have to satisfy until 2019, a year later than was previously required.According to a new timeline issued by the CMS Wednesday in the final Medicare Hospital...
by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Kaiser Permanente will be tested to repeat the record $1 billion in operating income it posted in the first quarter.After all, the Oakland, Calif.-based hospital and managed-care giant is swimming against the same national trends that dented the earnings of...
by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital
Enlarge this image Marcus Hutchins, seen in May when he was credited with hobbling the WannaCry attack. Now, U.S. authorities have arrested him for allegedly creating and distributing banking malware. Frank Augstein/AP hide caption toggle caption Frank Augstein/AP...
by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Technology, Working Capital
Lately, I have been enjoying the celebrity geek-off between Elon Musk and Mark Zuckerberg, who have very different opinions about whether AI will be an unequivocally good thing for human society. I guess I was as scared as the next guy the first time I saw Arnold...
by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Working Capital
Intel Corp. is expanding its San Jose self-driving car R&D lab and bringing on more automaker partners to collaborate with as it continues on its furious race to outpace other chipmakers in the autonomous vehicle space.
by synergycap1 | Aug 3, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Stephen Ubl wants to accelerate competition in the drug industry. That, he said, is one way to slow the pace of price increases for pharmaceuticals, not to mention keep such rogue actors as Martin Shkreli and Turing Pharmaceuticals in check. Ubl, who took over as CEO...